Author, as appears in the article.: Vitallé J, Terrén I, Orrantia A, Pérez-Garay R, Vidal F, Iribarren JA, Rodríguez C, Lirola AML, Bernal E, Zenarruzabeitia O, Borrego F
Department: Medicina i Cirurgia
URV's Author/s: Vidal Marsal, Francisco
Thematic Areas: Medicine (miscellaneous) Medicina iii Medicina ii Medicina i Infectious diseases Immunology and allergy Immunology Farmacia Ciências biológicas i
licence for use: https://creativecommons.org/licenses/by/3.0/es/
ISSN: 16727681
Author's mail: francesc.vidal@urv.cat
Author identifier: 0000-0002-6692-6186
Record's date: 2023-02-18
Papper version: info:eu-repo/semantics/publishedVersion
Link to the original source: https://www.nature.com/articles/s41423-019-0275-4
Papper original source: Cellular & Molecular Immunology. 16 (12): 940-942
APA: Vitallé J, Terrén I, Orrantia A, Pérez-Garay R, Vidal F, Iribarren JA, Rodríguez C, Lirola AML, Bernal E, Zenarruzabeitia O, Borrego F (2019). CD300a inhibits CD16-mediated NK cell effector functions in HIV-1-infected patients. Cellular & Molecular Immunology, 16(12), 940-942. DOI: 10.1038/s41423-019-0275-4
Licence document URL: https://repositori.urv.cat/ca/proteccio-de-dades/
Article's DOI: 10.1038/s41423-019-0275-4
Entity: Universitat Rovira i Virgili
Journal publication year: 2019
Publication Type: Journal Publications
Repositori URV